Podcasts / Panel discussion on GLP1s for chronic kidney disease in Type 2 Diabetes
Save


0.5 hours
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
0 hours
These are activities that require reflection on feedback about your work.
0 hours
These are activities that use your work data to ensure quality results.
Educational Activities (EA)
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
Reviewing Performance (RP)
These are activities that require reflection on feedback about your work.
Measuring Outcomes (MO)
These are activities that use your work data to ensure quality results.
65% of GPs rated this lecture as excellent.
The benefits of the GLP-1 receptor agonists are now recognised to extend beyond improving glycaemic control and effecting weight loss in patients with type 2 diabetes. Take chronic kidney disease for example. In this panel discussion, Nephrologist, Professor Genie Pedagogos and Endocrinologist, Professor Richard MacIsaac will be asked about the evidence for and role of GLP-1 receptor agonists in the prevention and management of kidney disease in patients with type 2 diabetes and will provide practical advice for clinicians wanting to offer this treatment option to their diabetic patients.

Cardiovascular Risk and Fatty Liver Disease

Importance of Early & Effective Treatment of Mild to Moderate Acne

SGLT2s and Renal Protection

CV Medications – Practical Strategies to Improve Compliance
Browse the latest podcasts from Healthed.
You have completed the Educational Activities (EA) component of this activity.
Select ‘Confirm & claim CPD‘ to confirm you have engaged with this activity in its entirety and claim your CPD.
You will be taken to explore further CPD learning available to you.
